Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Alzheimer's Disease

Free Subscription 14.09.2026 1 Acta Neuropathol 2 Alzheimer Dis Assoc Disord 13 Alzheimers Dement 1 BMJ 1 Brain 6 Curr Alzheimer Res 1 Dement Geriatr Cogn Disord 2 Exp Neurol 7 J Alzheimers Dis 1 J Biol Chem 2 J Neurol 1 J Neurosci 5 Lancet Neurol 1 Nat Med 2 Nat Neurosci 2 Neurobiol Aging 1 Neuroscience 1 PLoS One 1 Proc Natl Acad Sci U S A 1 Science

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Acta Neuropathol

1. MULVEY B, Divecha HR, Tippani M, Bach SV, et al
   Molecular programs in human locus coeruleus link APOE and neuromelanin to Alzheimer's vulnerability.
   Acta Neuropathol. 2026;152:32.
   PubMed         Abstract available
   
   

   
   Alzheimer Dis Assoc Disord

2. KIM MH, Colantonio LD, Glymour MM, Hamad R, et al
   Discordance Between Cognitive Impairment Status and Claims-Based ADRD Diagnosis: Temporal Patterns and Racial Differences in the REGARDS Cohort, 2006 to 2021.
   Alzheimer Dis Assoc Disord. 2026;40:183-191.
   PubMed         Abstract available
   
   
3. PAUDEL A, Galik E, Murphy TE, Boltz M, et al
   Content Validity of the Quality of Interactions Inventory (QUALII) in Assisted Living.
   Alzheimer Dis Assoc Disord. 2026;40:224-232.
   PubMed         Abstract available
   
   

   
   Alzheimers Dement

4. GEL A, Phillips E, Hausle I, Thropp P, et al
   MCH-Guard: Multimodal machine learning framework for risk stratification of cerebral microhemorrhage risk in the Alzheimer's Disease Neuroimaging Initiative.
   Alzheimers Dement. 2026;22:e71818.
   PubMed         Abstract available
   
   
5. RASTEGAR-POUYANI S, Lew C, Pereira FL, Satpati A, et al
   Tau-associated neuronal loss in the intermediate nucleus of the human hypothalamus, a putative VLPO analog, in progressive supranuclear palsy and Alzheimer's disease.
   Alzheimers Dement. 2026;22:e71808.
   PubMed         Abstract available
   
   
6. LANGFORD O, Raman R, Aisen P, Sperling R, et al
   More efficient screening for preclinical Alzheimer's clinical trials using mixture of experts.
   Alzheimers Dement. 2026;22:e71681.
   PubMed         Abstract available
   
   
7. REEVES MM, Calliari A, Todd TW, Maroto Cidfuentes C, et al
   TMEM106B is a selective modulator of TDP-43 pathology in Alzheimer's disease.
   Alzheimers Dement. 2026;22:e71713.
   PubMed         Abstract available
   
   
8. LUTZ MW, Man Z, Chiba-Falek O
   Cellular transcriptomic signatures underpinning the heterogeneity of depression in Alzheimer's disease.
   Alzheimers Dement. 2026;22:e71823.
   PubMed         Abstract available
   
   
9. BELTRAN-URBANO X, Jobson KR, Nasrallah IM, Kumar A, et al
   SynthPET: A 3D generative AI approach for FDG-PET image synthesis from T1-weighted MRI and ASL CBF in Alzheimer's disease.
   Alzheimers Dement. 2026;22:e71822.
   PubMed         Abstract available
   
   
10. PELLEGRINI C, Ravaioli F, De Fanti S, Siliquini A, et al
    Alterations of gut microbiota in Down syndrome and their association with Alzheimer's disease.
    Alzheimers Dement. 2026;22:e71815.
    PubMed         Abstract available
    
    
11. OTTMAN R, Wetmore JB, Leu CS, Uhlmann WR, et al
    Psychological impacts of APOE genotype disclosure among Latinos in New York City: a randomized controlled trial.
    Alzheimers Dement. 2026;22:e71796.
    PubMed         Abstract available
    
    
12. GROLLERO D, Gabb V, Blackman J, Heslegrave A, et al
    Are infraslow oscillations the missing link between sleep and Alzheimer's?
    Alzheimers Dement. 2026;22:e71525.
    PubMed         Abstract available
    
    
13. CHAI L, Huang Y, Ni J, Zuo S, et al
    A meta-refined human Alzheimer's disease-associated gene subset shows partial mouse-model pathway correspondence and limited cross-cohort machine-learning transportability.
    Alzheimers Dement. 2026;22:e71804.
    PubMed         Abstract available
    
    
14. ZHANG Z, Cao L, Liu P, Yang S, et al
    Distinct ocular microvascular alterations in Alzheimer's disease and cerebral small vessel disease.
    Alzheimers Dement. 2026;22:e71809.
    PubMed         Abstract available
    
    
15. ENGELMANN GTO, de Alvarenga JC, Moro GCP, Bolanos Burgos IC, et al
    The Cog-Aging: a 15-year cohort study of cognition in Brazilian older adults.
    Alzheimers Dement. 2026;22:e71780.
    PubMed         Abstract available
    
    
16. BHATTARAI S, Foster EG, Kadry R, Lu Y, et al
    Increased Amyloidogenic Neuronal Injury in HIV-1-infected APP-KI Alzheimer's disease mice.
    Alzheimers Dement. 2026;22:e71807.
    PubMed         Abstract available
    
    

    
    BMJ

17. WISE J
    Alzheimer's prevention drug trial: is a "statin for the brain" on the horizon?
    BMJ. 2026;394:e100822.
    PubMed        
    
    

    
    Brain

18. COGSWELL PM, Lundt ES, Therneau TM, Hu M, et al
    Modelling the temporal evolution of plasma p-tau217, amyloid PET, tau PET and cognition.
    Brain. 2026 Feb 25:awag075. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    Curr Alzheimer Res

19. ERSAN S, Ozmen E, Sari I, Ersan EE, et al
    Altered Epoxyeicosatrienoic Acid Signaling in Advanced-Stage Alzheimer's Disease (Investigation of Epoxyeicosatrienoic Acid Levels in Patients with Advanced Alzheimer's Disease).
    Curr Alzheimer Res. 2026 Sep 4. doi: 10.2174/0115672050468773260821110356.
    PubMed         Abstract available
    
    
20. GOU KJ, Chen Y, Sheng Z, Yu W, et al
    Psychotropic Polypharmacy in Alzheimer's Disease: A Potentially Inappropriate Medication Perspective in Older Adults.
    Curr Alzheimer Res. 2026 Aug 28. doi: 10.2174/0115672050502495260812063626.
    PubMed         Abstract available
    
    
21. EDELBACH B, Huang L, Boling W
    Vagus Nerve Stimulation in the Management of Neurodegenerative Diseases: A Systematic Review of Advances in Animal Research and Clinical Applications.
    Curr Alzheimer Res. 2026;23:270-282.
    PubMed         Abstract available
    
    
22. LIU H, Hescham S, Clusmann H, Temel Y, et al
    Causal Effects Between Neurodegenerative Diseases, Metabolites, and Brain Volume.
    Curr Alzheimer Res. 2026;23:283-297.
    PubMed         Abstract available
    
    
23. YU W, Guo Y, Peng J, Wang C, et al
    A DTI-Radiomics and Clinical Integration Model for Predicting MCI-to-AD Progression Using Corpus Callosum Features.
    Curr Alzheimer Res. 2026;23:189-199.
    PubMed         Abstract available
    
    
24. WANG J, Wang X, An Z, Wang X, et al
    Quantitative Proteomic Analysis of APP/PS1 Transgenic Mice.
    Curr Alzheimer Res. 2026;23:339-348.
    PubMed         Abstract available
    
    

    
    Dement Geriatr Cogn Disord

25. HONJO Y, Kawasaki I, Nagai K, Yuri T, et al
    Longitudinal Association between Day Service Use and Regular Memory Clinic Attendance in Alzheimer's Disease: A 3-Year Retrospective Observation of Completers.
    Dement Geriatr Cogn Disord. 2026 Sep 8:1. doi: 10.1159.
    PubMed         Abstract available
    
    

    
    Exp Neurol

26. LIU Y, Peng L, Li M, Yan W, et al
    Corrigendum to "Let-7d-5p improves mouse cognitive function by targeting bach1 in Alzheimer's disease" [Exp. Neurol. 406 (2026) 115957; https://doi.org/10.1016/j.expneurol.2026.115957].
    Exp Neurol. 2026 Sep 8:116016. doi: 10.1016/j.expneurol.2026.116016.
    PubMed        
    
    
27. ZHANG R, Yu T, Hao K, Yu Y, et al
    Non-linear association of blood urea nitrogen with low cognitive performance: Translational evidence from murine models and human population analysis.
    Exp Neurol. 2026;406:115996.
    PubMed         Abstract available
    
    

    
    J Alzheimers Dis

28. CUI T, Han X, Yao Q, Xu C, et al
    Clinical efficacy of non-pharmacological interventions on cognitive improvement in patients with mild to moderate Alzheimer's disease: A systematic review and Bayesian network meta-analysis.
    J Alzheimers Dis. 2026 Sep 12:13872877261485496. doi: 10.1177/13872877261485496.
    PubMed         Abstract available
    
    
29. LI Q, Xiao J, Deng G, Zhong H, et al
    Circ_0004801 promotes tau hyperphosphorylation and cognitive impairment in Alzheimer's disease through the miR-7688-5p/TTBK1 axis.
    J Alzheimers Dis. 2026 Sep 11:13872877261487120. doi: 10.1177/13872877261487120.
    PubMed         Abstract available
    
    
30. WALKER E, Rodriguez-Carmona Y, Wang X, Mukherjee B, et al
    Cadmium exposure and incidence of all-cause dementia and Alzheimer's disease in US adults.
    J Alzheimers Dis. 2026 Sep 11:13872877261487104. doi: 10.1177/13872877261487104.
    PubMed         Abstract available
    
    
31. PEREIRA DA SILVA AM, Haddad Santos D
    GLP-1 receptor agonism in Alzheimer's disease after EVOKE: From single hypothesis to stratified program.
    J Alzheimers Dis. 2026 Sep 10:13872877261485580. doi: 10.1177/13872877261485580.
    PubMed         Abstract available
    
    
32. ILARDI A, Ilardi CR
    Thyroid dysfunction: Another piece in the complex puzzle of Alzheimer's disease?
    J Alzheimers Dis. 2026 Sep 7:13872877261485579. doi: 10.1177/13872877261485579.
    PubMed         Abstract available
    
    
33. RUITENBERG MFL, Carmona Osorio PD, King JB, Hoffman JM, et al
    Motor sequence learning and learning to learn across the Alzheimer's disease continuum: Associations with biomarkers.
    J Alzheimers Dis. 2026 Sep 8:13872877261485584. doi: 10.1177/13872877261485584.
    PubMed         Abstract available
    
    
34. LI OY, Turnbull A, Vankee-Lin F
    Stage-dependent associations of glial fibrillary acidic protein and chitinase-3-like protein 1 with white matter network integrity in Alzheimer's disease.
    J Alzheimers Dis. 2026 Sep 8:13872877261485599. doi: 10.1177/13872877261485599.
    PubMed         Abstract available
    
    

    
    J Biol Chem

35. ZHANG J, Zhu Y, Zhang Q, Dai Y, et al
    Monomeric C-Reactive Protein Potentiates Microglia-Mediated Neuroinflammation in Alzheimer's Disease via the PLC-PKC-MAPK-NF-kappaB Pathway.
    J Biol Chem. 2026 Sep 8:113527. doi: 10.1016/j.jbc.2026.113527.
    PubMed         Abstract available
    
    

    
    J Neurol

36. ELGENIDI A, Shir D, Piura YD, Sokol LL, et al
    Prion disease mimicking rapidly progressive Alzheimer disease: case series and systematic review.
    J Neurol. 2026;273:565.
    PubMed         Abstract available
    
    
37. AIELLO EN, Canu E, Castelnovo V, Frisco F, et al
    Discriminating behavioral variant frontotemporal dementia from Alzheimer's disease via the Frontal Assessment Battery.
    J Neurol. 2026;273:585.
    PubMed         Abstract available
    
    

    
    J Neurosci

38. 
    Erratum: Li et al., "Amelioration of Symptomatic Alzheimer's Disease after Selective Impairment of p75(NTR) Function in Adult Forebrain Excitatory Neurons".
    J Neurosci. 2026 Sep 11:e1374262026. doi: 10.1523/JNEUROSCI.1374-26.2026.
    PubMed        
    
    

    
    Lancet Neurol

39. BENZINGER TLS, Cogswell PM, Arani A, Chaney AM, et al
    Neuroimaging in the era of biologically defined Alzheimer's disease and disease-modifying therapy.
    Lancet Neurol. 2026;25:939-951.
    PubMed         Abstract available
    
    
40. TEUNISSEN CE, Vermunt L, Barthelemy NR, Benzinger TLS, et al
    Fluid biomarkers in the evolving care landscape of Alzheimer's disease and related disorders.
    Lancet Neurol. 2026;25:926-938.
    PubMed         Abstract available
    
    
41. LAN G, Guo T
    Charting the future of biomarkers and therapy in Alzheimer's disease.
    Lancet Neurol. 2026;25:879-880.
    PubMed        
    
    
42. THE LANCET NEUROLOGY
    Alzheimer's disease testing needs evidence, ethics, and equity.
    Lancet Neurol. 2026;25:873.
    PubMed        
    
    
43. GRAFF-RADFORD J, Karliner L, Barnes DE, Frisoni GB, et al
    Clinical pathways for cognitively unimpaired individuals with Alzheimer's disease neuropathological change.
    Lancet Neurol. 2026;25:952-964.
    PubMed         Abstract available
    
    

    
    Nat Med

44. WANG Z, Wang S, Liang Y, Chen X, et al
    Joint impact of pathological burden and cognitive resilience on Alzheimer's disease risk.
    Nat Med. 2026 Sep 11. doi: 10.1038/s41591-026-04635.
    PubMed         Abstract available
    
    

    
    Nat Neurosci

45. ABELLANAS MA, Basurco L, Purnapatre M, Burgaletto C, et al
    Bone marrow myelopoiesis dysfunction in Alzheimer's disease limits monocyte homing to the brain and drives disease progression.
    Nat Neurosci. 2026 Sep 8. doi: 10.1038/s41593-026-02417.
    PubMed         Abstract available
    
    
46. 
    The hidden role of the bone marrow in Alzheimer's disease.
    Nat Neurosci. 2026 Sep 8. doi: 10.1038/s41593-026-02418.
    PubMed        
    
    

    
    Neurobiol Aging

47. DZIANOK P, Wojciechowski J, Wolak T, Kublik E, et al
    Subtle cortical thinning in the temporal pole in middle-aged APOE-epsilon4 and PICALM (rs3851179) AA/AG carriers without dementia.
    Neurobiol Aging. 2026;168:63-72.
    PubMed         Abstract available
    
    
48. VANDERLIP CR, Lingad JN, Treadwell Z, Loritsch JM, et al
    Amyloid-associated cognitive trajectories in aging dogs mirror early changes in humans.
    Neurobiol Aging. 2026;168:99-108.
    PubMed         Abstract available
    
    

    
    Neuroscience

49. BASAVARAJU KC, Harshitha DK, Priyadarshini P
    Alcohol-induced dysregulation of tau and acetylation pathways in the pathogenesis of Alzheimer's disease.
    Neuroscience. 2026 Sep 10:S0306-4522(26)00623.
    PubMed         Abstract available
    
    

    
    PLoS One

50. WU H, Zhang N, Yan W, Li C, et al
    Abortive transcripts in exosomes - A potential biomarker for Alzheimer's disease.
    PLoS One. 2026;21:e0357752.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

51. DU X, Liu N, Zhang T, Yang C, et al
    Size-tailored nanoparticle-antibody conjugates overcome hepatic sequestration in Alzheimer's disease treatment.
    Proc Natl Acad Sci U S A. 2026;123:e2603034123.
    PubMed         Abstract available
    
    

    
    Science

52. SMITH JE
    Clues to immune havoc in the brain.
    Science. 2026;393:1070-1071.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Alzheimer's Disease is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum